REIT - Specialty
Compare Stocks
5 / 10Stock Comparison
SBAC vs WELL vs AMT vs VTR vs CCI
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
REIT - Specialty
REIT - Healthcare Facilities
REIT - Specialty
SBAC vs WELL vs AMT vs VTR vs CCI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | REIT - Specialty | REIT - Healthcare Facilities | REIT - Specialty | REIT - Healthcare Facilities | REIT - Specialty |
| Market Cap | $23.19B | $149.25B | $83.69B | $41.15B | $39.74B |
| Revenue (TTM) | $2.85B | $11.63B | $10.82B | $6.13B | $4.21B |
| Net Income (TTM) | $1.02B | $1.43B | $2.88B | $260M | $1.06B |
| Gross Margin | 63.6% | 39.1% | 73.4% | -4.3% | 65.7% |
| Operating Margin | 47.6% | 4.4% | 44.2% | 13.4% | 48.0% |
| Forward P/E | 29.4x | 78.4x | 27.4x | 118.0x | 43.9x |
| Total Debt | $15.32B | $21.38B | $44.96B | $13.22B | $29.57B |
| Cash & Equiv. | $432M | $5.03B | $1.47B | $741M | $269M |
SBAC vs WELL vs AMT vs VTR vs CCI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| SBA Communications … (SBAC) | 100 | 69.6 | -30.4% |
| Welltower Inc. (WELL) | 100 | 420.4 | +320.4% |
| American Tower Corp… (AMT) | 100 | 69.6 | -30.4% |
| Ventas, Inc. (VTR) | 100 | 247.6 | +147.6% |
| Crown Castle Inc. (CCI) | 100 | 52.9 | -47.1% |
Price return only. Dividends and distributions are not included.
Quick Verdict: SBAC vs WELL vs AMT vs VTR vs CCI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
SBAC carries the broadest edge in this set and is the clearest fit for valuation efficiency.
- PEG 0.25 vs AMT's 3.76
- Lower P/E (29.4x vs 118.0x)
- 35.7% margin vs VTR's 4.2%
- 9.0% ROA vs VTR's 1.0%, ROIC 10.0% vs 2.5%
WELL is the #2 pick in this set and the best alternative if long-term compounding and sleep-well-at-night is your priority.
- 223.1% 10Y total return vs SBAC's 138.9%
- Lower volatility, beta 0.13, Low D/E 49.5%, current ratio 5.34x
- 35.8% FFO/revenue growth vs CCI's -35.1%
- +42.7% vs AMT's -15.0%
Among these 5 stocks, AMT doesn't own a clear edge in any measured category.
VTR ranks third and is worth considering specifically for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.01, yield 2.1%
- Rev growth 18.5%, EPS growth 184.2%, 3Y rev CAGR 12.2%
- Beta 0.01, yield 2.1%, current ratio 0.96x
- Beta 0.01 vs CCI's 0.26
CCI is the clearest fit if your priority is dividends.
- 5.2% yield, vs AMT's 3.7%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.8% FFO/revenue growth vs CCI's -35.1% | |
| Value | Lower P/E (29.4x vs 118.0x) | |
| Quality / Margins | 35.7% margin vs VTR's 4.2% | |
| Stability / Safety | Beta 0.01 vs CCI's 0.26 | |
| Dividends | 5.2% yield, vs AMT's 3.7% | |
| Momentum (1Y) | +42.7% vs AMT's -15.0% | |
| Efficiency (ROA) | 9.0% ROA vs VTR's 1.0%, ROIC 10.0% vs 2.5% |
SBAC vs WELL vs AMT vs VTR vs CCI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
SBAC vs WELL vs AMT vs VTR vs CCI — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CCI leads in 1 of 6 categories
SBAC leads 1 • WELL leads 1 • AMT leads 0 • VTR leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
CCI leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
WELL is the larger business by revenue, generating $11.6B annually — 4.1x SBAC's $2.9B. SBAC is the more profitable business, keeping 35.7% of every revenue dollar as net income compared to VTR's 4.2%. On growth, WELL holds the edge at +40.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $2.9B | $11.6B | $10.8B | $6.1B | $4.2B |
| EBITDAEarnings before interest/tax | $1.7B | $2.8B | $6.9B | $2.3B | $2.7B |
| Net IncomeAfter-tax profit | $1.0B | $1.4B | $2.9B | $260M | $1.1B |
| Free Cash FlowCash after capex | $1.0B | $2.5B | $3.8B | $1.4B | $2.7B |
| Gross MarginGross profit ÷ Revenue | +63.6% | +39.1% | +73.4% | -4.3% | +65.7% |
| Operating MarginEBIT ÷ Revenue | +47.6% | +4.4% | +44.2% | +13.4% | +48.0% |
| Net MarginNet income ÷ Revenue | +35.7% | +12.3% | +26.6% | +4.2% | +25.1% |
| FCF MarginFCF ÷ Revenue | +35.7% | +21.9% | +34.9% | +22.4% | +64.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +5.9% | +40.3% | +6.8% | +22.0% | -4.8% |
| EPS Growth (YoY)Latest quarter vs prior year | -14.7% | +22.5% | +76.9% | 0.0% | +132.1% |
Valuation Metrics
Evenly matched — SBAC and AMT and VTR each lead in 2 of 7 comparable metrics.
Valuation Metrics
At 22.3x trailing earnings, SBAC trades at a 86% valuation discount to VTR's 160.3x P/E. Adjusting for growth (PEG ratio), SBAC offers better value at 0.19x vs AMT's 4.57x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $23.2B | $149.2B | $83.7B | $41.1B | $39.7B |
| Enterprise ValueMkt cap + debt − cash | $38.1B | $165.6B | $127.2B | $53.6B | $69.0B |
| Trailing P/EPrice ÷ TTM EPS | 22.31x | 153.25x | 33.33x | 160.26x | 89.28x |
| Forward P/EPrice ÷ next-FY EPS est. | 29.39x | 78.42x | 27.41x | 118.01x | 43.94x |
| PEG RatioP/E ÷ EPS growth rate | 0.19x | — | 4.57x | — | — |
| EV / EBITDAEnterprise value multiple | 20.62x | 66.40x | 18.32x | 24.31x | 24.94x |
| Price / SalesMarket cap ÷ Revenue | 8.24x | 13.99x | 7.86x | 7.05x | 9.32x |
| Price / BookPrice ÷ Book value/share | — | 3.35x | 8.14x | 3.18x | — |
| Price / FCFMarket cap ÷ FCF | 21.74x | 52.41x | 22.12x | 31.25x | 13.82x |
Profitability & Efficiency
SBAC leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
AMT delivers a 27.4% return on equity — every $100 of shareholder capital generates $27 in annual profit, vs $2 for VTR. WELL carries lower financial leverage with a 0.49x debt-to-equity ratio, signaling a more conservative balance sheet compared to AMT's 4.34x. On the Piotroski fundamental quality scale (0–9), SBAC scores 7/9 vs CCI's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | — | +3.5% | +27.4% | +2.1% | — |
| ROA (TTM)Return on assets | +9.0% | +2.3% | +4.5% | +1.0% | +3.4% |
| ROICReturn on invested capital | +10.0% | +0.5% | +6.9% | +2.5% | +5.5% |
| ROCEReturn on capital employed | +14.5% | +0.6% | +8.6% | +3.2% | +7.2% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 7 | 6 | 4 |
| Debt / EquityFinancial leverage | — | 0.49x | 4.34x | 1.05x | — |
| Net DebtTotal debt minus cash | $14.9B | $16.3B | $43.5B | $12.5B | $29.3B |
| Cash & Equiv.Liquid assets | $432M | $5.0B | $1.5B | $741M | $269M |
| Total DebtShort + long-term debt | $15.3B | $21.4B | $45.0B | $13.2B | $29.6B |
| Interest CoverageEBIT ÷ Interest expense | 3.65x | 0.26x | 3.99x | 1.40x | 2.17x |
Total Returns (Dividends Reinvested)
WELL leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in WELL five years ago would be worth $30,234 today (with dividends reinvested), compared to $6,519 for CCI. Over the past 12 months, WELL leads with a +42.7% total return vs AMT's -15.0%. The 3-year compound annual growth rate (CAGR) favors WELL at 42.5% vs CCI's -2.5% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +14.2% | +14.3% | +3.8% | +12.6% | +3.9% |
| 1-Year ReturnPast 12 months | -7.1% | +42.7% | -15.0% | +33.9% | -9.0% |
| 3-Year ReturnCumulative with dividends | -1.0% | +189.5% | +3.3% | +94.2% | -7.3% |
| 5-Year ReturnCumulative with dividends | -18.8% | +202.3% | -14.7% | +74.8% | -34.8% |
| 10-Year ReturnCumulative with dividends | +138.9% | +223.1% | +113.8% | +65.0% | +57.9% |
| CAGR (3Y)Annualised 3-year return | -0.3% | +42.5% | +1.1% | +24.8% | -2.5% |
Risk & Volatility
Evenly matched — AMT and VTR each lead in 1 of 2 comparable metrics.
Risk & Volatility
AMT is the less volatile stock with a -0.04 beta — it tends to amplify market swings less than CCI's 0.26 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. VTR currently trades 97.8% from its 52-week high vs AMT's 76.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.16x | 0.13x | -0.04x | 0.01x | 0.26x |
| 52-Week HighHighest price in past year | $244.19 | $219.59 | $234.33 | $88.50 | $115.76 |
| 52-Week LowLowest price in past year | $162.41 | $142.65 | $165.08 | $61.76 | $75.96 |
| % of 52W HighCurrent price vs 52-week peak | +89.5% | +97.0% | +76.7% | +97.8% | +78.7% |
| RSI (14)Momentum oscillator 0–100 | 58.0 | 60.2 | 52.4 | 56.2 | 59.5 |
| Avg Volume (50D)Average daily shares traded | 1.2M | 2.6M | 2.8M | 3.4M | 2.9M |
Analyst Outlook
Evenly matched — AMT and CCI each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: SBAC as "Buy", WELL as "Buy", AMT as "Buy", VTR as "Buy", CCI as "Buy". Consensus price targets imply 20.4% upside for AMT (target: $216) vs 4.9% for VTR (target: $91). For income investors, CCI offers the higher dividend yield at 5.23% vs WELL's 1.30%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $230.14 | $226.50 | $216.33 | $90.80 | $105.40 |
| # AnalystsCovering analysts | 42 | 34 | 49 | 32 | 46 |
| Dividend YieldAnnual dividend ÷ price | +2.0% | +1.3% | +3.7% | +2.1% | +5.2% |
| Dividend StreakConsecutive years of raises | 7 | 2 | 11 | 1 | 0 |
| Dividend / ShareAnnual DPS | $4.45 | $2.76 | $6.73 | $1.86 | $4.76 |
| Buyback YieldShare repurchases ÷ mkt cap | +2.1% | 0.0% | +0.4% | 0.0% | +0.1% |
CCI leads in 1 of 6 categories (Income & Cash Flow). SBAC leads in 1 (Profitability & Efficiency). 3 tied.
SBAC vs WELL vs AMT vs VTR vs CCI: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is SBAC or WELL or AMT or VTR or CCI a better buy right now?
For growth investors, Welltower Inc.
(WELL) is the stronger pick with 35. 8% revenue growth year-over-year, versus -35. 1% for Crown Castle Inc. (CCI). SBA Communications Corporation (SBAC) offers the better valuation at 22. 3x trailing P/E (29. 4x forward), making it the more compelling value choice. Analysts rate SBA Communications Corporation (SBAC) a "Buy" — based on 42 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — SBAC or WELL or AMT or VTR or CCI?
On trailing P/E, SBA Communications Corporation (SBAC) is the cheapest at 22.
3x versus Ventas, Inc. at 160. 3x. On forward P/E, American Tower Corporation is actually cheaper at 27. 4x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: SBA Communications Corporation wins at 0. 25x versus American Tower Corporation's 3. 76x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — SBAC or WELL or AMT or VTR or CCI?
Over the past 5 years, Welltower Inc.
(WELL) delivered a total return of +202. 3%, compared to -34. 8% for Crown Castle Inc. (CCI). Over 10 years, the gap is even starker: WELL returned +223. 1% versus CCI's +57. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — SBAC or WELL or AMT or VTR or CCI?
By beta (market sensitivity over 5 years), American Tower Corporation (AMT) is the lower-risk stock at -0.
04β versus Crown Castle Inc. 's 0. 26β — meaning CCI is approximately -801% more volatile than AMT relative to the S&P 500. On balance sheet safety, Welltower Inc. (WELL) carries a lower debt/equity ratio of 49% versus 4% for American Tower Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — SBAC or WELL or AMT or VTR or CCI?
By revenue growth (latest reported year), Welltower Inc.
(WELL) is pulling ahead at 35. 8% versus -35. 1% for Crown Castle Inc. (CCI). On earnings-per-share growth, the picture is similar: Ventas, Inc. grew EPS 184. 2% year-over-year, compared to -11. 5% for Welltower Inc.. Over a 3-year CAGR, WELL leads at 22. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — SBAC or WELL or AMT or VTR or CCI?
SBA Communications Corporation (SBAC) is the more profitable company, earning 37.
4% net margin versus 4. 3% for Ventas, Inc. — meaning it keeps 37. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CCI leads at 48. 7% versus 3. 3% for WELL. At the gross margin level — before operating expenses — AMT leads at 73. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is SBAC or WELL or AMT or VTR or CCI more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, SBA Communications Corporation (SBAC) is the more undervalued stock at a PEG of 0. 25x versus American Tower Corporation's 3. 76x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, American Tower Corporation (AMT) trades at 27. 4x forward P/E versus 118. 0x for Ventas, Inc. — 90. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for AMT: 20. 4% to $216. 33.
08Which pays a better dividend — SBAC or WELL or AMT or VTR or CCI?
All stocks in this comparison pay dividends.
Crown Castle Inc. (CCI) offers the highest yield at 5. 2%, versus 1. 3% for Welltower Inc. (WELL).
09Is SBAC or WELL or AMT or VTR or CCI better for a retirement portfolio?
For long-horizon retirement investors, American Tower Corporation (AMT) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
04), 3. 7% yield, +113. 8% 10Y return). Both have compounded well over 10 years (AMT: +113. 8%, CCI: +57. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between SBAC and WELL and AMT and VTR and CCI?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: SBAC is a mid-cap quality compounder stock; WELL is a mid-cap high-growth stock; AMT is a mid-cap income-oriented stock; VTR is a mid-cap high-growth stock; CCI is a mid-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.